STAT

Meet the doctor who helped inspire a controversial Netflix movie about anorexia

A hotly debated Netflix movie on anorexia, "To the Bone," was written and directed by a former patient of Dr. Richard MacKenzie, who treats eating disorders.

At age 78, Dr. Richard MacKenzie is having his Hollywood moment.

He’s the physician who helped inspire a controversial Netflix movie about anorexia, “To the Bone,” which begins streaming on Friday. The film was written and directed by one of his former patients, Marti Noxon. She has credited MacKenzie with helping her overcome her struggles with anorexia and bulimia.

But “To the Bone” is hardly a faithful portrait of his work. Over a long but under-the-radar career at Children’s Hospital Los Angeles, MacKenzie focused on keeping patients in their homes, rather than admitting them to an inpatient treatment center. He was known for working with his patients, with warmth and sensitivity, to help them identify the issues behind their eating disorders.

His character in “To The Bone,” by contrast, is brusque and edgy — and runs a group home to treat patients with anorexia.

MacKenzie never worked in such  and has watched their the number a decade ago, according to a count published last year. But their treatments are rarely fully covered by insurance and they often offer services, like equine therapy, that aren’t based in evidence.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readChemistry
STAT+: Pharmalittle: We’re Reading About Fake Studies, AbbVie Investing In Psychedelics, And More
Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost revenue.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related